Ki67 in breast cancer: prognostic and predictive potential von Yerushalmi, Rinat, Dr, Woods, Ryan, MSc, Ravdin, Peter M, MD, Hayes, Malcolm M, MD, Gelmon, Karen A, MD

Volltext

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer von Cardoso, Fatima, van’t Veer, Laura J, Bogaerts, Jan, Slaets, Leen, Viale, Giuseppe, Delaloge, Suzette, Pierga, Jean-Yves, Brain, Etienne, Causeret, Sylvain, DeLorenzi, Mauro, Glas, Annuska M, Golfinopoulos, Vassilis, Goulioti, Theodora, Knox, Susan, Matos, Erika, Meulemans, Bart, Neijenhuis, Peter A, Nitz, Ulrike, Passalacqua, Rodolfo, Ravdin, Peter, Rubio, Isabel T, Saghatchian, Mahasti, Smilde, Tineke J, Sotiriou, Christos, Stork, Lisette, Straehle, Carolyn, Thomas, Geraldine, Thompson, Alastair M, van der Hoeven, Jacobus M, Vuylsteke, Peter, Bernards, René, Tryfonidis, Konstantinos, Rutgers, Emiel, Piccart, Martine

Volltext

The HER‐2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER‐2 Therapy and Personalized Medicine von Ross, Jeffrey S., Slodkowska, Elzbieta A., Symmans, W. Fraser, Pusztai, Lajos, Ravdin, Peter M., Hortobagyi, Gabriel N.

Volltext

The Decrease in Breast-Cancer Incidence in 2003 in the United States von Ravdin, Peter M, Cronin, Kathleen A, Howlader, Nadia, Berg, Christine D, Chlebowski, Rowan T, Feuer, Eric J, Edwards, Brenda K, Berry, Donald A

Volltext

High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller von GONZALEZ-ANGULO, Ana M, LITTON, Jennifer K, LARSIMONT, Denis, FEOLI, Francesco, STRANZL, Heidi, BUCHHOLZ, Thomas A, VALERO, Vicente, THERIAULT, Richard, PICCART-GEBHART, Martine, RAVDIN, Peter M, BERRY, Donald A, HORTOBAGYI, Gabriel N, BROGLIO, Kristine R, MERIC-BERNSTAM, Funda, RAKKHIT, Ronjay, CARDOSO, Fatima, PEINTINGER, Florentia, HANRAHAN, Emer O, SAHIN, Aysegul, GURAY, Merih

Volltext

American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer von HARRIS, Lyndsay, FRITSCHE, Herbert, MENNEL, Robert, NORTON, Larry, RAVDIN, Peter, TAUBE, Sheila, SOMERFIELD, Mark R, HAYES, Daniel F, BAST, Robert C

Volltext

Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features von GOLDSTEIN, Lori J, GRAY, Robert, SLEDGE, George W, PEREZ, Edith A, SHULMAN, Lawrence N, MARTINO, Silvana, SPARANO, Joseph A, BADVE, Sunil, CHILDS, Barrett H, YOSHIZAWA, Carl, ROWLEY, Steve, SHAK, Steven, BAEHNER, Frederick L, RAVDIN, Peter M, DAVIDSON, Nancy E

Volltext

Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer von OLIVOTTO, Ivo A, BAJDIK, Chris D, RAVDIN, Peter M, SPEERS, Caroline H, COLDMAN, Andrew J, NORRIS, Brian D, DAVIS, Greg J, CHIA, Stephen K, GELMON, Karen A

Volltext

Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women von Chlebowski, Rowan T, Anderson, Garnet L, Gass, Margery, Lane, Dorothy S, Aragaki, Aaron K, Kuller, Lewis H, Manson, JoAnn E, Stefanick, Marcia L, Ockene, Judith, Sarto, Gloria E, Johnson, Karen C, Wactawski-Wende, Jean, Ravdin, Peter M, Schenken, Robert, Hendrix, Susan L, Rajkovic, Aleksandar, Rohan, Thomas E, Yasmeen, Shagufta, Prentice, Ross L, WHI Investigators, for the

Volltext

Computer Program to Assist in Making Decisions About Adjuvant Therapy for Women With Early Breast Cancer von RAVDIN, Peter M, SIMINOFF, Laura A, DAVIS, Greg J, MERCER, Mary Beth, HEWLETT, Joan, GERSON, Nancy, PARKER, Helen L

Volltext

Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study von Mook, Stella, MD, Schmidt, Marjanka K, PhD, Rutgers, Emiel J, Prof, van de Velde, Anthonie O, BSc, Visser, Otto, MD, Rutgers, Sterre M, MSc, Armstrong, Nicola, PhD, van't Veer, Laura J, Dr, Ravdin, Peter M, MD

Volltext

The lack, need, and opportunities for decision-making and informational tools to educate primary-care physicians and women about breast cancer chemoprevention von Ravdin, Peter M

Volltext

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer von Sparano, Joseph A, Gray, Robert J, Ravdin, Peter M, Makower, Della F, Pritchard, Kathleen I, Albain, Kathy S, Hayes, Daniel F, Geyer, Charles E, Dees, Elizabeth C, Goetz, Matthew P, Olson, John A, Lively, Tracy, Badve, Sunil S, Saphner, Thomas J, Wagner, Lynne I, Whelan, Timothy J, Ellis, Matthew J, Paik, Soonmyung, Wood, William C, Keane, Maccon M, Gomez Moreno, Henry L, Reddy, Pavan S, Goggins, Timothy F, Mayer, Ingrid A, Brufsky, Adam M, Toppmeyer, Deborah L, Kaklamani, Virginia G, Berenberg, Jeffrey L, Abrams, Jeffrey, Sledge, George W

Volltext

Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women von Chlebowski, Rowan T, Kuller, Lewis H, Prentice, Ross L, Stefanick, Marcia L, Manson, JoAnn E, Gass, Margery, Aragaki, Aaron K, Ockene, Judith K, Lane, Dorothy S, Sarto, Gloria E, Rajkovic, Aleksandar, Schenken, Robert, Hendrix, Susan L, Ravdin, Peter M, Rohan, Thomas E, Yasmeen, Shagufta, Anderson, Garnet

Volltext

Prediction Model for Estimating the Survival Benefit of Adjuvant Radiotherapy for Gallbladder Cancer von WANG, Samuel J, FULLER, C. David, KIM, Jong-Sung, SITTIG, Dean F, THOMAS, Charles R, RAVDIN, Peter M

Volltext

Independent Prognostic Value of Screen Detection in Invasive Breast Cancer von MOOK, Stella, VAN 'T VEER, Laura J, RUTGERS, Emiel J, RAVDIN, Peter M, VAN DE VELDE, Anthonie O, VAN LEEUWEN, Flora E, VISSER, Otto, SCHMIDT, Marjanka K

Volltext

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial von Albain, Kathy S, Prof, Barlow, William E, Prof, Ravdin, Peter M, Prof, Farrar, William B, Prof, Burton, Gary V, Prof, Ketchel, Steven J, MD, Cobau, Charles D, MD, Levine, Ellis G, MD, Ingle, James N, Prof, Pritchard, Kathleen I, Prof, Lichter, Allen S, Prof, Schneider, Daniel J, MD, Abeloff, Martin D, Prof, Henderson, I Craig, Prof, Muss, Hyman B, Prof, Green, Stephanie J, Prof, Lew, Danika, MA, Livingston, Robert B, Prof, Martino, Silvana, DO, Osborne, C Kent, Prof

Volltext

The EORTC 10041/BIG 03-04 MINDACT trial is feasible: Results of the pilot phase von Rutgers, Emiel, Piccart-Gebhart, Martine J, Bogaerts, Jan, Delaloge, Suzette, Veer, Laura Van ‘t, Rubio, Isabel Teresa, Viale, Giuseppe, Thompson, Alastair M, Passalacqua, Rodolfo, Nitz, Ulrike, Vindevoghel, Anita, Pierga, Jean-Yves, Ravdin, Peter M, Werutsky, Gustavo, Cardoso, Fatima

Volltext

Epidemiology of GIST in the Era of Histology Codes--Letter von Lin, Albert, Hsing, Ann W, Ravdin, Peter M

Volltext

A decision aid to assist in adjuvant therapy choices for breast cancer von Siminoff, Laura A., Gordon, Nahida H., Silverman, Paula, Budd, Thomas, Ravdin, Peter M.

Volltext